Compare Bristol-Myers Squibb Co (BMY) vs Cenovus Energy Inc (CVE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bristol-Myers Squibb Co vs Cenovus Energy Inc — how do they compare? Bristol-Myers Squibb Co trades at $63.7 (market cap $129.94B), while Cenovus Energy Inc trades at $29.96 (market cap $55.00B). The key difference: Bristol-Myers Squibb Co is far larger — about 2.4× Cenovus Energy Inc's market cap, and Bristol-Myers Squibb Co pays the higher dividend (3.96%). Which is the better fit depends on your goals.
| BMY | CVE | |
|---|---|---|
Market Cap | $129.94B | $55.00B |
Sector | Health | Energy |
52-Week High | $65.89 | $31.80 |
52-Week Low | $42.60 | $14.83 |
Enterprise Value | $163.92B | $61.08B |
Dividend Yield | 3.96% | 2.09% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bristol-Myers Squibb Co
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Unlike some of its more diversified peers, Bristol has exited several nonpharmaceutical businesses to focus on branded specialty drugs, which tend to support strong pricing power.
Read more on BMY →About Cenovus Energy Inc
Cenovus Energy is an integrated oil company, focused on creating value through the development of its oil sands assets. The company also engages in production of conventional crude oil, natural gas liquids, and natural gas in Alberta, Canada, with refining operations in the U.S. Net upstream production averaged 472 thousand barrels of oil equivalent per day in 2020, and the company estimates that it holds 6.7 billion boe of proven and probable reserves.
Read more on CVE →
